TTR-stabilising medicines for the treatment of transthyretin amyloid cardiomyopathy
Cochrane Database of Systematic Reviews · 20.11.2026 · 2026 (11)
DOI: 10.1002/14651858.cd016420 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cochrane Database of Systematic Reviews, online erschienen am 20.11.2026. Verfasst von Philippa Garbutt und 5 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Garbutt, P., Quill, S., Greenbaum, T., Lopes, L. R., Gillmore, J. D., & Schmidt, A. F. (2026). TTR-stabilising medicines for the treatment of transthyretin amyloid cardiomyopathy. Cochrane Database of Systematic Reviews, 2026(11). https://doi.org/10.1002/14651858.cd016420
Vancouver
Garbutt P, Quill S, Greenbaum T, Lopes LR, Gillmore JD, Schmidt AF. TTR-stabilising medicines for the treatment of transthyretin amyloid cardiomyopathy. Cochrane Database of Systematic Reviews. 2026;2026(11). doi:10.1002/14651858.cd016420
BibTeX
@article{Garbutt2026,
author = {Garbutt, Philippa and Quill, Sam and Greenbaum, Talia and Lopes, Luis R and Gillmore, Julian D. and Schmidt, Amand F.},
title = {TTR-stabilising medicines for the treatment of transthyretin amyloid cardiomyopathy},
journal = {Cochrane Database of Systematic Reviews},
year = {2026},
volume = {2026},
number = {11},
doi = {10.1002/14651858.cd016420}
}
EUVIMED